Ausgabe 10/2009
Inhalt (17 Artikel)
A systematic review of humoral immune responses against tumor antigens
Miriam Reuschenbach, Magnus von Knebel Doeberitz, Nicolas Wentzensen
Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
Ussama M. Abdel-Motal, Kim Wigglesworth, Uri Galili
Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases
Thomas Josef Vogl, Thaddäus T. Wissniowski, Nagy N. N. Naguib, Renate M. Hammerstingl, Martin G. Mack, Sabine Münch, Matthias Ocker, Deike Strobel, Eckhart G. Hahn, Johannes Hänsler
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2
Hanh K. Le, Laura Graham, Catriona H. T. Miller, Maciej Kmieciak, Masoud H. Manjili, Harry Douglas Bear
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
Taku Nagai, Masashi Tanaka, Yasuhiro Tsuneyoshi, Baohui Xu, Sara A. Michie, Kazuhisa Hasui, Hirofumi Hirano, Kazunori Arita, Takami Matsuyama
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses
Jun Zhou, Desheng Weng, Fangjian Zhou, Ke Pan, Haifeng Song, Qijing Wang, Huan Wang, Hui Wang, Yongqiang Li, Lixi Huang, Huakun Zhang, Wei Huang, Jianchuan Xia
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma
Hildur Helgadottir, Emilia Andersson, Lisa Villabona, Lena Kanter, Henk van der Zanden, Geert W. Haasnoot, Barbara Seliger, Kjell Bergfeldt, Johan Hansson, Boel Ragnarsson-Olding, Rolf Kiessling, Giuseppe Valentino Masucci
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
Jon Amund Kyte, Sissel Trachsel, Bente Risberg, Per thor Straten, Kari Lislerud, Gustav Gaudernack
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi, François Ghiringhelli, Lin Chen, Antoine F. Carpentier
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
Craig Gedye, Juliet Quirk, Judy Browning, Suzanne Svobodová, Thomas John, Pavel Sluka, P. Rod Dunbar, Denis Corbeil, Jonathan Cebon, Ian D. Davis
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro
Wujiang Liu, Michael A. O’Donnell, Xiaohong Chen, Ruifa Han, Yi Luo
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
Eyad Elkord, Adam Dangoor, Deborah J. Burt, Thomas D. Southgate, Sai Daayana, Richard Harrop, Jan W. Drijfhout, David Sherlock, Robert E. Hawkins, Peter L. Stern
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response
Stéphanie Delluc, Patricia Hachem, Sylvie Rusakiewicz, Auguste Gaston, Carmen Marchiol-Fournigault, Lea Tourneur, Narjes Babchia, Didier Fradelizi, Armelle Regnault, Kim Hanh Le Quan Sang, Gilles Chiocchia, Agnès Buzyn
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures
Wendy Ingram, Shahram Kordasti, Lucas Chan, Linda D. Barber, Gee J. Tye, Nicola Hardwick, Ghulam J. Mufti, Farzin Farzaneh
Anti-cancer activity and mechanistic features of a NK cell activating molecule
Hyung-Ran Kim, Kyoung-Ho Lee, Su Jung Park, So Young Kim, Young Keun Yang, Jinsung Tae, Jongsun Kim
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
Cedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, Timothy M. Clay, Michael Kalos, Holden Maecker, Kunle Odunsi, Michael Pride, Lloyd Old, Axel Hoos, Pedro Romero
Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy
Robert T. O’Donnell, David Pearson, Hayes C. McKnight, Ya Peng Ma, Joseph M. Tuscano